Abstract
Sudden cardiac death (SCD) is one of the most common causes of death in developed countries, with most SCDs involving the elderly, and structural heart disease evident at autopsy. Each year, however, thousands of sudden deaths involving individuals younger than 35 years of age remain unexplained after a comprehensive medicolegal investigation that includes an autopsy. In fact, several epidemiologic studies have estimated that at least 3% and up to 53% of sudden deaths involving previously healthy children, adolescents, and young adults show no morphologic abnormalities identifiable at autopsy. Cardiac channelopathies associated with structurally normal hearts such as long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS) yield no evidence to be found at autopsy, leaving coroners, medical examiners, and forensic pathologists only to speculate that a lethal arrhythmia might lie at the heart of a sudden unexplained death (SUD). In cases of autopsy-negative SUD, continued investigation through either a cardiologic and genetic evaluation of first- or second-degree relatives or a molecular autopsy may elucidate the underlying mechanism contributing to the sudden death and allow for identification of living family members with the pathogenic substrate that renders them vulnerable, with an increased risk for cardiac events including syncope, cardiac arrest, and sudden death.
Similar content being viewed by others
References
Ackerman MJ, Clapham DE (1998) Ion channels: basic science and clinical disease. N Engl J Med. 336:1575–1586
Ackerman MJ (2004) Cardiac channelopathies: it’s in the genes. Nat Med 10:463–464
Ackerman MJ (2005) Cardiac causes of sudden unexpected death in children and their relationship to seizures and syncope: genetic testing for cardiac electropathies. Semin Pediatr Neurol 12:52–58
Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA (2001) Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286:2264–2269
Ackerman MJ, Tester DJ, Driscoll DJ (2001) Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol 22:105–111
Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP (2011) HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies. This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 8:1308–1339
Arnestad M, Vege A, Rognum TO (2002) Evaluation of diagnostic tools applied in the examination of sudden unexpected deaths in infancy and early childhood. Forensic Sci Int 125:262–268
Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ (2007) Prevalence of long QT syndrome gene variants in sudden infant death syndrome. Circulation 115:361–367
Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, Thiene G, van der Wal A, Association for European Cardiovascular Pathalogy (2008) Guidelines for autopsy investigation of sudden cardiac death. Virchows Archiv 452:11–18
Basso C, Carturan E, Pilichou K, Rizzo S, Corrado D, Thiene G (2010) Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol 19:321–325
Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, Davies MJ, McKenna W (2003) Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 362:1457
Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ (2008) Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 29:1670–1680
Brugada P, Benito B, Brugada R, Brugada J (2009) Brugada syndrome: update 2009. HJC Hellenic J Cardiol 50:352–372
Burke AP, Farb A, Virmani R, Goodin J, Smialek JE (1991) Sports-related and non–sports-related sudden cardiac death in young adults. Am Heart J 121:568–575
Carturan E, Tester DJ, Thiene G, Ackerman MJ (2006) Evaluation of different DNA extraction methods in archival heart tissue for postmortem mutational analysis (abstract 1518). Mod Pathol 19:325A–326A
Chen PS, Priori SG (2008) The Brugada syndrome. J Am Coll Cardiol 51:1176–1180
Chugh SS, Kelly KL, Titus JL (2000) Sudden cardiac death with apparently normal heart. Circulation 102:649–654
Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, Titus JL, Hayflick SJ (2004) Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol 43:1625–1629
Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50:399–408
Cote A, Russo P, Michaud J (1999) Sudden unexpected deaths in infancy: what are the causes? J Pediatr 135:437–443
Creighton W, Virmani R, Kutys R, Burke A (2006) Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn 8:62–67
Crotti L (2011) Genetic predisposition to sudden cardiac death. Curr Opin Cardiol 26:46–50
di Gioia CRT, Autore C, Romeo DM, Ciallella C, Aromatario MR, Lopez A, Pagannone E, Giordano C, Gallo P, d’Amati G (2006) Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine. Hum Pathol 37:794–801
Di Paolo M, Luchini D, Bloise R, Priori SG (2004) Postmortem molecular analysis in victims of sudden unexplained death. Am J Forensic Med Pathol 25:182–184
Doolan A, Langlois N, Semsarian C (2004) Causes of sudden cardiac death in young Australians. Med Aust 180:110–112
Dwyer T, Ponsonby AL, Blizzard L, Newman NM, Cochrane JA (1995) The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA 273:783–789
Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R (2004) Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141:829–834
Eldar M, Pras E, Lahat H (2003) A missense mutation in the CASQ2 gene is associated with autosomal- recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med 13:148–151
Fabre A, Sheppard MN (2006) Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart 92:316–320
Filiano JJ, Kinney HC (1994) A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol Neonate 65:194–197
Fleming PJ, Blair PS, Bacon C, Bensley D, Smith I, Taylor E, Berry J, Golding J, Tripp J (1996) Environment of infants during sleep and risk of the sudden infant death syndrome: results of 1993–1995 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry Into Stillbirths and Deaths Regional Coordinators and Researchers (see comment). BMJ 313:191–195
Getahun D, Amre D, Rhoads GG, Demissie K (2004) Maternal and obstetric risk factors for sudden infant death syndrome in the United States. Obstet Gynecol 103:646–652
Gladding PA, Evans CA, Crawford J, Chung SK, Vaughan A, Webster D, Neas K, Love DR, Rees MI, Shelling AN, Skinner JR (2010) Posthumous diagnosis of long QT syndrome from neonatal screening cards. Heart Rhythm 7:481–486
Goldenberg I, Moss AJ, Zareba W (2005) Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes. Curr Cardiol Rep 7:349–356
Guntheroth WG (1989) Theories of cardiovascular causes in sudden infant death syndrome. J Am Coll Cardiol 14:443–447
Hoffman HJ, Hillman LS (1992) Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol 19:717–737
Hoffman HJ, Damus K, Hillman L, Krongrad E (1988) Risk factors for SIDS. results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study. Ann N Y Acad Sci 533:13–30
Kanda I, Endo M (1997) Coronary artery spasm: a hypothesis on prevention by progesterone. Med Hypotheses 49:183–185
Kinney HC, Thach BT (2009) The sudden infant death syndrome. N Engl J Med 361:795–805
Lahat H, Eldar M, Levy-Nissenbaum E et al (2001) Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 103:2822–2827
Laitinen PJ, Brown KM, Piippo K, Swam H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K, Nava A, Bagattin A, Stanchi F, Larderet G, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A (2001) Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103:485–490
Lee A, Ackerman MJ (2003) Sudden unexplained death: evaluation of those left behind. Lancet 362:1429–1431
Liberthson RR (1996) Sudden death from cardiac causes in children and young adults. N Engl J Med 334:1039–1044
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO (1996) Sudden death in young competitive athletes: clinical, demographic, and pathological profiles (see comment). JAMA 276:199–204
Michaud K, Fellmann F, Abriel H, Beckmann JS, Mangin P, Elger BS (2009) Molecular autopsy in sudden cardiac death and its implication for families: discussion of the practical, legal, and ethical aspects of the multidisciplinary collaboration. Swiss Med Weekly 139:712–718
Morentin B, Suarez-Mier MP, Aguilera B (2003) Sudden unexplained death among persons 1–35 years old. Forensic Sci Int 135:213–217
Moss AJ, Robinson J (1992) Clinical features of the idiopathic long QT syndrome. Circulation 85:I140–I144
Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, Bottelli G, Cerrone M, Leonardi S (2005) Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice (see comment). JAMA 294:2975–2980
Nishio H, Iwata M, Suzuki K (2006) Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death: R420 W mutated case with characteristics of status thymico-lymphatics. Circ J 70:1402–1406
Ponsonby AL, Dwyer T, Gibbons LE, Cochrane JA, Wang YG (1993) Factors potentiating the risk of sudden infant death syndrome associated with the prone position (see comment). N Eng J Med 329:377–382
Priori SG, Napolitano C, Schwartz PJ (1999) Low penetrance in the long QT syndrome: clinical impact. Circulation 99:529–533
Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M (2000) Brugada syndrome and sudden cardiac death in children. Lancet 355:808–809
Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196–200
Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz FES, Vignati G, Benatar A, DeLogu A (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106:69–74
Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA (2005) Sudden death in the young. Heart Rhythm 2:1277–1282
Ruan Y, Liu N, Priori SG (2009) Sodium channel mutations and arrhythmias. Nat Rev Cardiol 6:337–348
Shimizu W (2008) Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 72:1926–1936
Skinner JR, Crawford J, Smith W, Aitken A, Heaven D, Evans C-A, Hayes I, Neas KR, Stables S, Koelmeyer T, Denmark L, Vuletic J, Maxwell F, White K, Yang T, Roden DM, Leren TP, Shelling A, Love DR, Cardiac Inherited Disease Group of New Zealand (2011) Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1- to 40-year-olds. Heart Rhythm 8:412–419
Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA (2005) Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112:207–213
Tester DJ, Ackerman MJ (2005) Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res 67:388–396
Tester DJ, Ackerman MJ (2006) The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 21:166–172
Tester DJ, Ackerman MJ (2007) Postmortem long QT syndrome genetic testing for sudden unexplained death in the young (see comment). J Am Coll Cardiol 49:240–246
Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ (2004) Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cases. Mayo Clin Proc 79:1380–1384
Tester DJ, Kopplin LJ, Will ML, Ackerman MJ (2005) Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2:1099–1105
Tester DJ, Will ML, Haglund CM, Ackerman MJ (2005) Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2:507–517
Valdes-Dapena MA (1973) Editorial: sudden, unexpected and unexplained death in infancy: a status report–1973. N Engl J Med 289:1195–1197
van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal AC, van Langen IM, Wilde AAM (2010) Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 7:1383–1389
Vincent GM, Timothy KW, Leppert M, Keating M (1992) The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 327:846–852
Vincent GM, Timothy K, Fox J, Zhang L (1999) The inherited long QT syndrome: from ion channel to bedside. Cardiol Rev 7:44–55
Virmani R, Burke AP, Farb A (2001) Sudden cardiac death. Cardiovasc Pathol 10:275–282
Weese-Mayer DE, Ackerman MJ, Marazita ML, Berry-Kravis EM (2007) Sudden infant death syndrome: review of implicated genetic factors. Am J Med Genet 143:771–788
Wever EF, Robles de Medina EO (2004) Sudden death in patients without structural heart disease. J Am Coll Cardiol 43:1137–1144
Willinger M, James LS, Catz C (1991) Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 11:677–684
Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL, Bundgaard H, Svendsen JH, Haunso S, Tfelt-Hansen J (2011) Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur Heart J 32:983–990
Wisten A, Forsberg H, Krantz P, Messner T (2002) Sudden cardiac death in 15- to 35-year-olds in Sweden during 1992–1999. J Intern Med 252:529–536
Yun AJ, Lee PY (2004) Sudden death among infants and adults: companion disorders of maladaptive sympathetic bias. Med Hypotheses 62:857–860
Disclosures
Michael J. Ackerman is a consultant for Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Inc., and Transgenomic. Intellectual property derived from his research program resulted in license agreements in 2004 between Mayo Clinic Health Solutions (formerly Mayo Medical Ventures) and PGxHealth (formerly Genaissance Pharmaceuticals, now recently acquired by Transgenomic). David J. Tester has no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tester, D.J., Ackerman, M.J. The Molecular Autopsy: Should the Evaluation Continue After the Funeral?. Pediatr Cardiol 33, 461–470 (2012). https://doi.org/10.1007/s00246-012-0160-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0160-8